Evidence map›Paper›PMID 30526524›Full record

ArticleBMC cancer2018

Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells.

Marina Teras, Edda Viisileht, Merlis Pahtma-Hall, Airi Rump, Viiu Paalme, Pille Pata, Illar Pata, Christelle Langevin, Sirje Rüütel Boudinot

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. The Role of Apoptin in Chicken Anemia Virus Replication.Pathogens (Basel, Switzerland) · 2020
    Review
  6. Apoptosis Triggered by ORF3 Proteins of theFrontiers in cellular and infection microbiology · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Marina TerasOncology, North Estonia Medical Centre, 19 J. Sütiste tee st, 13419, Tallinn, Estonia.
Edda ViisilehtOncology, North Estonia Medical Centre, 19 J. Sütiste tee st, 13419, Tallinn, Estonia.
Merlis Pahtma-HallDepartment of Chemistry and Biotechnology, Tallinn University of Technology, 15 Akadeemia St, 12618, Tallinn, Estonia.
Airi RumpDepartment of Chemistry and Biotechnology, Tallinn University of Technology, 15 Akadeemia St, 12618, Tallinn, Estonia.
Viiu PaalmeDepartment of Chemistry and Biotechnology, Tallinn University of Technology, 15 Akadeemia St, 12618, Tallinn, Estonia.
Pille PataDepartment of Chemistry and Biotechnology, Tallinn University of Technology, 15 Akadeemia St, 12618, Tallinn, Estonia.
Illar PataIVEX Lab OU, 15 Akadeemia St, 12618, Tallinn, Estonia.
Christelle LangevinVirologie et Immunologie Moléculaires, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.
Sirje Rüütel BoudinotDepartment of Chemistry and Biotechnology, Tallinn University of Technology, 15 Akadeemia St, 12618, Tallinn, Estonia. sirje.boudinot@gmail.com.
Tallinn University of Technology · EENorth Estonia Medical Centre · EEVirologie et Immunologie Moléculaires · FR

Funding

EGIDE 885510BEstonian research council PUT685Estonian research council SF0140066s09estonian science fondation ETF8914European Regional Development Fund (ASTRA) 2014-2020.4.01.16-0032
6 · The paper itself

Abstract

backgroundThe current treatment of malignant melanoma is limited by the lack of effective therapeutic approaches, and alternative treatments are needed. Proliferative diseases such as melanoma and other cancers may be treatable by virally-encoded apoptotic proteins that are targeted to rapidly multiplying cells. Caspase-dependent apoptosis, that is frequently used in chemotherapy, can boost the cell proliferation that caspase-independent cell death does not.

methodsIn the current study, the porcine circovirus type 2 (PCV2), proapoptotic protein ORF3 was expressed in mouse and human cancer cell lines, and its apoptotic activity was assessed.

resultsQuantitative assessment of the apoptotic cells by flow cytometry showed that apoptotic cell death was significantly increased in ORF3-expressing malignant cells, compared to ORF3 non-expressing cells. Our data show that PCV2 ORF3 induces apoptosis in a caspase-3 and -8 independent manner. ORF3 expression seems to cause an increase in abnormal mitosis in B16F10 melanoma cells by interacting with centrosomes and thereby disrupting the formation of the mitotic spindle. In addition, we show that ORF3 of PCV2 also exhibits significant anti-tumor effects in vivo. Although the expression of Regulator of G protein Signaling (RGS)-16 by recipient mice inhibited the development of grafted melanoma in vivo, it was not required for the antitumoral activity of ORF3.

conclusionPCV2 ORF3 causes abnormal mitosis in rapidly dividing cells and increases the apoptosis of cancer cells. Apoptin might, therefore, be considered to develop future antitumoral strategies.

Indexed as

ApoptosisCircovirusViral ProteinsAnimalsCell Line, TumorHumansMelanomaMiceMice, Inbred C57BLMice, KnockoutOncolytic VirotherapyOncolytic VirusesViral ProteinsApoptosisMelanomaPorcine circovirus type 2 (PCV2) ORF3

Identifiers

PMID30526524
PMCPMC6288936
OpenAlexW2904352743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.